Literature DB >> 18403275

Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing.

D Y Graham1, M Kato, M Asaka.   

Abstract

BACKGROUND: The acceptance of the premise that Helicobacter pylori infection is aetiologically related to gastric cancer and peptic ulcer and that the risk of gastric cancer among Helicobacter pylori infected individuals is related to the extent, severity and duration of atrophic gastritis has led to major changes in medical and endoscopic practices. The development of non-invasive methods to detect Helicobacter pylori and to estimate the extent and severity of gastritis has reduced the need for diagnostic endoscopy in asymptomatic individuals. METHODS AND
RESULTS: Here we provide recommendations regarding deciding whether non-invasive and endoscopic assessment of the gastric mucosa is preferred. We also include specific recommendations and caveats regarding the preferred biopsy number and sites as well as the identification of specimens, to allow the pathologist to reliable stage the severity and extent of gastritis, and thus provide prognostic information needed for patient managements (e.g., whether endoscopic surveillance is recommended).
CONCLUSION: In summary, while there is clearly a role for gastric endoscopy and endoscopic biopsy in the Helicobacter pylori era, obtaining useful diagnostic and prognostic information is critically dependent upon attention to detail with regard to biopsy site and identification as to the location from where the specimen was taken.

Entities:  

Mesh:

Year:  2008        PMID: 18403275      PMCID: PMC2525514          DOI: 10.1016/j.dld.2008.02.032

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  24 in total

1.  Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication.

Authors:  David Y Graham; Akiko Shiotani; Hala M T El-Zimaity
Journal:  Gastrointest Endosc       Date:  2006-09-01       Impact factor: 9.427

2.  Gastritis in the Japanese stomach.

Authors:  K Kimura; K Satoh; K Ido; Y Taniguchi; T Takimoto; T Takemoto
Journal:  Scand J Gastroenterol Suppl       Date:  1996

3.  Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.

Authors:  S Maeda; H Yoshida; K Ogura; Y Yamaji; T Ikenoue; T Mitsushima; H Tagawa; R Kawaguchi; K Mori; K i Mafune; T Kawabe; Y Shiratori; M Omata
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states.

Authors:  G N Stemmermann; T Hayashi
Journal:  J Natl Cancer Inst       Date:  1968-09       Impact factor: 13.506

5.  Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharidases with "Tes-Tape".

Authors:  T Kawachi; K Kogure; N Tanaka; A Tokunaga; T Sugimura
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

6.  Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach.

Authors:  K Kimura
Journal:  Gastroenterology       Date:  1972-10       Impact factor: 22.682

7.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

8.  Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.

Authors:  B Annibale; M R Aprile; G D'ambra; P Caruana; C Bordi; G Delle Fave
Journal:  Aliment Pharmacol Ther       Date:  2000-05       Impact factor: 8.171

9.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

10.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

Authors:  A M Ekström; M Held; L E Hansson; L Engstrand; O Nyrén
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

View more
  6 in total

1.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Pyloric metaplasia, pseudopyloric metaplasia, ulcer-associated cell lineage and spasmolytic polypeptide-expressing metaplasia: reparative lineages in the gastrointestinal mucosa.

Authors:  James R Goldenring
Journal:  J Pathol       Date:  2018-04-14       Impact factor: 7.996

3.  Histomorphological Characteristics and Pathological Types of Hyperproliferation of Gastric Surface Epithelial Cells.

Authors:  Yangkun Wang; Lan Shen; Guang Zhao; Baohui Li; Jianxue Bu; Chaoya Zhu; Bo Jiang; Sunan Wang
Journal:  Gastroenterol Res Pract       Date:  2021-03-09       Impact factor: 2.260

Review 4.  Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.

Authors:  David Y Graham; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-08-28       Impact factor: 7.527

5.  Feasibility of confocal endomicroscopy in the diagnosis of pediatric gastrointestinal disorders.

Authors:  Krishnappa Venkatesh; Marta Cohen; Clair Evans; Peter Delaney; Steven Thomas; Christopher Taylor; Ashraf Abou-Taleb; Ralf Kiesslich; Mike Thomson
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

6.  Panel of serum biomarkers (GastroPanel) in diagnosis of atrophic gastritis and Helicobacter pylori infection: a protocol of systematic review and meta-analysis.

Authors:  Dan Wu; Anya Shi; Haiping Wang; Xiuzhong Yu
Journal:  BMJ Open       Date:  2022-09-28       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.